{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:27:40Z","timestamp":1790162860555,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K08623"],"award-info":[{"award-number":["JP22K08623"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Association for Lower Limb Artery Revascularization"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Patients undergoing revascularization for lower extremity arterial disease (LEAD) may face a higher risk of mortality than those with coronary artery disease (CAD). This study aimed to characterize the difference in mortality risk between patients undergoing revascularization for LEAD and CAD and identify associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The 1-year database of 10 754 patients undergoing revascularization for CAD (n = 6349) and LEAD (n = 4405) was analysed. Poisson regression models were used to characterize interpopulation differences in mortality, adjusting for baseline clinical features, including age, sex, polyvascular disease, comorbidities, medications, and vulnerabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Individuals with LEAD were older, were more likely to have polyvascular disease, had more comorbidities, and received fewer cardioprotective drugs than those with CAD. Vulnerabilities remained more common in the LEAD group even after adjusting for these clinical features. The crude risk ratio of mortality incidence for LEAD vs. CAD was 2.91 (95% confidence interval, 2.54\u20133.34), attenuated to 2.14 (1.83\u20132.50) after controlling for age, sex, and polyvascular disease. The percentage attenuation in the excessive mortality associated with LEAD was 29%. The stepwise addition of comorbidities, medications, and vulnerabilities as adjusting factors attenuated the incidence risk ratio to 1.48 (1.26\u20131.72), 1.33 (1.12\u20131.58), and 1.17 (0.98\u20131.39), respectively, and increased the percentage attenuation to 64%, 73%, and 86%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mortality risk was almost three-fold higher in patients undergoing revascularization for LEAD than in those with CAD. The excessive mortality was considerably attributable to inter-group differences in baseline characteristics, including potentially clinically or socially modifiable factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehae207","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T02:43:22Z","timestamp":1710989002000},"page":"1634-1643","source":"Crossref","is-referenced-by-count":23,"title":["Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-041X","authenticated-orcid":false,"given":"Mitsuyoshi","family":"Takahara","sequence":"first","affiliation":[{"name":"Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine , 2-2 Yamadaoka, Suita City, Osaka 565-0871 , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1931-5769","authenticated-orcid":false,"given":"Yoshimitsu","family":"Soga","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kokura Memorial Hospital , Kitakyushu City , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-7304","authenticated-orcid":false,"given":"Osamu","family":"Iida","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital , Osaka City , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"2024051307061095800_ehae207-B1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.acvd.2019.05.009","article-title":"Epidemiology, treatment patterns and outcomes in patients with coronary or lower extremity artery disease in France","volume":"112","author":"Guedeney","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"2024051307061095800_ehae207-B2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5551\/jat.53330","article-title":"Presentation pattern of lower extremity endovascular intervention versus percutaneous coronary intervention","volume":"27","author":"Takahara","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"2024051307061095800_ehae207-B3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejvs.2018.01.019","article-title":"Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome","volume":"55","author":"Sartipy","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2024051307061095800_ehae207-B4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.5551\/jat.62356","article-title":"Association of age with mortality rate after femoropopliteal endovascular therapy for intermittent claudication","volume":"29","author":"Takahara","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"2024051307061095800_ehae207-B5","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"2024051307061095800_ehae207-B6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehp553","article-title":"Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease","volume":"31","author":"van Kuijk","year":"2010","journal-title":"Eur Heart J"},{"key":"2024051307061095800_ehae207-B7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/eci.12222","article-title":"The impact of polyvascular disease on long-term outcome in percutaneous coronary intervention patients","volume":"44","author":"van der Meer","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"2024051307061095800_ehae207-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2017.04.015","article-title":"Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death","volume":"262","author":"Zhang","year":"2017","journal-title":"Atherosclerosis"},{"key":"2024051307061095800_ehae207-B9","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1253\/circj.CJ-18-0105","article-title":"Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease\u2014short-term results of the Toma-Code Registry","volume":"82","author":"Higashitani","year":"2018","journal-title":"Circ J"},{"key":"2024051307061095800_ehae207-B10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/SLA.0000000000001676","article-title":"Endovascular versus open revascularization for peripheral arterial disease","volume":"265","author":"Wiseman","year":"2017","journal-title":"Ann Surg"},{"key":"2024051307061095800_ehae207-B11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"2024051307061095800_ehae207-B12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"2024051307061095800_ehae207-B13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nature06516","article-title":"The coming acceleration of global population ageing","volume":"451","author":"Lutz","year":"2008","journal-title":"Nature"},{"key":"2024051307061095800_ehae207-B14","doi-asserted-by":"crossref","first-page":"f6598","DOI":"10.1136\/bmj.f6598","article-title":"Population ageing: the timebomb that isn\u2019t?","volume":"347","author":"Spijker","year":"2013","journal-title":"BMJ"},{"key":"2024051307061095800_ehae207-B15","author":"Ministry of Health Labour and Welfare"},{"key":"2024051307061095800_ehae207-B16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2024051307061095800_ehae207-B17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","article-title":"Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients","volume":"82","author":"Bouillanne","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"2024051307061095800_ehae207-B18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"2024051307061095800_ehae207-B19","doi-asserted-by":"crossref","first-page":"e5452","DOI":"10.1136\/bmj.e5452","article-title":"Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study","volume":"345","author":"Stringhini","year":"2012","journal-title":"BMJ"},{"key":"2024051307061095800_ehae207-B20","doi-asserted-by":"crossref","first-page":"j2708","DOI":"10.1136\/bmj.j2708","article-title":"Childhood intelligence in relation to major causes of death in 68 year follow-up: prospective population study","volume":"357","author":"Calvin","year":"2017","journal-title":"BMJ"},{"key":"2024051307061095800_ehae207-B21","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1161\/CIRCULATIONAHA.122.059430","article-title":"Risk of macrovascular and microvascular disease in diabetes diagnosed using oral glucose tolerance test with and without confirmation by hemoglobin A1c: the Whitehall II cohort study","volume":"146","author":"Tabak","year":"2022","journal-title":"Circulation"},{"key":"2024051307061095800_ehae207-B22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jacc.2021.11.029","article-title":"Interventions for frailty among older adults with cardiovascular disease: JACC state-of-the-art review","volume":"79","author":"Ijaz","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2024051307061095800_ehae207-B23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacc.2014.12.040","article-title":"Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study","volume":"65","author":"Sergi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2024051307061095800_ehae207-B24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jgs.15584","article-title":"Functional trajectories of persons with cardiovascular disease in late life","volume":"67","author":"Keeney","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2024051307061095800_ehae207-B25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty assessment in the cardiovascular care of older adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2024051307061095800_ehae207-B26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jvs.2018.12.060","article-title":"Frailty and functional outcomes after open and endovascular procedures for patients with peripheral arterial disease: a systematic review","volume":"71","author":"van Aalst","year":"2020","journal-title":"J Vasc Surg"},{"key":"2024051307061095800_ehae207-B27","doi-asserted-by":"crossref","first-page":"101656","DOI":"10.1016\/j.arr.2022.101656","article-title":"Impact of frailty on all-cause mortality or major amputation in patients with lower extremity peripheral artery disease: a meta-analysis","volume":"79","author":"Zhang","year":"2022","journal-title":"Ageing Res Rev"},{"key":"2024051307061095800_ehae207-B28","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/j.jtcvs.2014.07.087","article-title":"The impact of frailty on outcomes after cardiac surgery: a systematic review","volume":"148","author":"Sepehri","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2024051307061095800_ehae207-B29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5551\/jat.61481","article-title":"Clinical impact of measures for frailty severity in poor-risk patients undergoing revascularization for chronic limb-threatening ischemia","volume":"29","author":"Takahara","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"2024051307061095800_ehae207-B30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"2024051307061095800_ehae207-B31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"2024051307061095800_ehae207-B32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation"},{"key":"2024051307061095800_ehae207-B33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12933-019-0955-5","article-title":"Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases","volume":"18","author":"Takahara","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2024051307061095800_ehae207-B34","author":"World Health Organization"},{"key":"2024051307061095800_ehae207-B35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurjpc\/zwaa167","article-title":"Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS)","volume":"29","author":"Richter","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2024051307061095800_ehae207-B36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2024051307061095800_ehae207-B37","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"2024051307061095800_ehae207-B38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/1526602820923118","article-title":"Impact of institutional volume on critical in-hospital complications adjusted for patient- and limb-related characteristics: an analysis of a nationwide Japanese registry of endovascular interventions for PAD","volume":"27","author":"Iida","year":"2020","journal-title":"J Endovasc Ther"},{"key":"2024051307061095800_ehae207-B39","first-page":"100434","article-title":"Percutaneous coronary intervention during the COVID-19 pandemic in Japan: insights from the nationwide registration data","volume":"22","author":"Yamaji","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"2024051307061095800_ehae207-B40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5551\/jat.64007","article-title":"Association of smoking, diabetes, and dialysis with the presence of popliteal lesions in femoropopliteal artery disease","volume":"30","author":"Takahara","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"2024051307061095800_ehae207-B41","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2013.01.054","article-title":"Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects","volume":"61","author":"Savji","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024051307061095800_ehae207-B42","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jvs.2017.08.078","article-title":"Grip strength measurement for frailty assessment in patients with vascular disease and associations with comorbidity, cardiac risk, and sarcopenia","volume":"67","author":"TEt","year":"2018","journal-title":"J Vasc Surg"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/18\/1634\/57568006\/ehae207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/18\/1634\/57568006\/ehae207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:08:04Z","timestamp":1715569684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/18\/1634\/7661025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":42,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,5,2]]},"published-print":{"date-parts":[[2024,5,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehae207","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,7]]},"published":{"date-parts":[[2024,5,2]]}}}